# Venatorx Pharmaceuticals, Inc.: funding, contracts (2026)

Registers read on November 19, 2026.

Venatorx Pharmaceuticals, Inc. (Pennsylvania) appears in 4 public registers SpecStream reads: 8 Form D filings, 6 federal contract awards, 2 certified H-1B and PERM cases and 13 NIH and NSF awards; the newest record is dated July 31, 2026, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 4
- Newest record: July 31, 2026
- State: Pennsylvania

## Form D filings (SEC)

8 Form D filings, newest July 13, 2023.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Form D amendment](https://specstream.ai/data/form-d/company/venatorx-pharmaceuticals-inc-1590501) | July 13, 2023 | $35 million sold of $48.2 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1590501/000180627023000001/0001806270-23-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/venatorx-pharmaceuticals-inc-1590501) | February 27, 2023 | $15 million sold of $16.4 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1590501/000159050123000001/0001590501-23-000001-index.htm) |
| [Form D amendment](https://specstream.ai/data/form-d/company/venatorx-pharmaceuticals-inc-1590501) | December 22, 2022 | $24.7 million sold of $24.7 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1590501/000159050122000004/0001590501-22-000004-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/venatorx-pharmaceuticals-inc-1590501) | September 2, 2022 | $12.7 million sold of $24.5 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1590501/000159050122000003/0001590501-22-000003-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/venatorx-pharmaceuticals-inc-1590501) | April 4, 2022 | $34 million sold of $60 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1590501/000159050122000001/0001590501-22-000001-index.htm) |
| [Form D amendment](https://specstream.ai/data/form-d/company/venatorx-pharmaceuticals-inc-1590501) | November 5, 2018 | $27.1 million sold of $47.1 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1590501/000159050118000001/0001590501-18-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/venatorx-pharmaceuticals-inc-1590501) | July 25, 2017 | $21.9 million sold of $42 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1590501/000159050117000001/0001590501-17-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/venatorx-pharmaceuticals-inc-1590501) | December 4, 2013 | $3.4 million sold of $4 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1590501/000159050113000001/0001590501-13-000001-index.htm) |

- [Venatorx Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/venatorx-pharmaceuticals-inc-1590501)
- [SEC EDGAR filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1590501&type=D)

## Federal contract awards (USAspending)

6 federal contract awards, newest July 31, 2026.

- UEI: MBBKNBU5DCC6
- Business size: Small Business
- Obligated: $15.6 million

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Department of Health and Human Services](https://specstream.ai/data/federal-awards/recipient/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | September 15, 2023 | Definitive Contract, NAICS 541714; $0 obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_75A50123C00050_7505_-NONE-_-NONE-/) |
| [Department of Health and Human Services](https://specstream.ai/data/federal-awards/recipient/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | September 27, 2022 | Definitive Contract, NAICS 541714; $0 obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_75A50122C00080_7505_-NONE-_-NONE-/) |
| [Department of Health and Human Services](https://specstream.ai/data/federal-awards/recipient/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | July 1, 2020 | Definitive Contract, NAICS 541715; $9.7 million obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_75N93020C00016_7529_-NONE-_-NONE-/) |
| [Department of Health and Human Services](https://specstream.ai/data/federal-awards/recipient/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | July 17, 2019 | Definitive Contract, NAICS 541714; $6.4 million obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_75A50119C00007_7505_-NONE-_-NONE-/) |
| [Department of Defense](https://specstream.ai/data/federal-awards/recipient/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | August 28, 2017 | Definitive Contract, NAICS 541711; $-460.2 thousand obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_HDTRA117C0070_9700_-NONE-_-NONE-/) |
| [Department of Health and Human Services](https://specstream.ai/data/federal-awards/recipient/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | September 19, 2016 | Definitive Contract, NAICS 541711; $18.9 thousand obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_HHSN272201600029C_7529_-NONE-_-NONE-/) |

- [VENATORX PHARMACEUTICALS INC](https://specstream.ai/data/federal-awards/recipient/venatorx-pharmaceuticals-inc-mbbknbu5dcc6)

## H-1B and PERM certifications (Department of Labor)

2 certified H-1B and PERM cases, newest February 27, 2024.

- EIN: 27-2782193

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Scientist II, Analytical Development](https://specstream.ai/data/hiring/employer/venatorx-pharmaceuticals-inc-272782193) | February 27, 2024 | H-1B, 1 case, $118 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2024_Q2.xlsx) |
| [Senior Formulation Scientist](https://specstream.ai/data/hiring/employer/venatorx-pharmaceuticals-inc-272782193) | July 28, 2023 | H-1B, 1 case, $112.7 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2023_Q4.xlsx) |

- [Venatorx Pharmaceuticals, Inc.](https://specstream.ai/data/hiring/employer/venatorx-pharmaceuticals-inc-272782193)

## NIH and NSF research awards

13 NIH and NSF awards, newest April 1, 2024.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [NIH](https://specstream.ai/data/research-funding/organization/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | April 1, 2024 | Novel Cyclic Boronate Cell Wall Inhibitors Targeting Carbapenem-Resistant Acinetobacter baumannii; $2 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/11064025) |
| [NIH](https://specstream.ai/data/research-funding/organization/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | July 24, 2023 | Discovery of antiviral inhibitors for the treatment of orthopoxvirus infections; $600 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10892864) |
| [NIH](https://specstream.ai/data/research-funding/organization/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | June 7, 2023 | Optimization of orally bioavailable inhibitors for the treatment of COVID-19 and other human coronavirus infections; $3 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/11091599) |
| [NIH](https://specstream.ai/data/research-funding/organization/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | March 10, 2022 | Broad spectrum β-lactamase inhibitors employing a Trojan horse mechanism to rescue β-lactams against multidrug-resistant Pseudomonas | [reporter.nih.gov](https://reporter.nih.gov/project-details/10773624) |
| [NIH](https://specstream.ai/data/research-funding/organization/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | May 24, 2021 | Preclinical development of capsid assembly modulators for the treatment of chronic hepatitis B virus infection; $3 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/10612081) |
| [NIH](https://specstream.ai/data/research-funding/organization/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | May 4, 2021 | Novel cyclic boronate Penicillin Binding Protein Inhibitors to eliminate the threat posed by β-lactamases and enable a future treatment | [reporter.nih.gov](https://reporter.nih.gov/project-details/11073038) |
| [NIH](https://specstream.ai/data/research-funding/organization/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | December 15, 2020 | Discovery of inhibitors that target HBx for the treatment of chronic HBV infection; $506.6 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10319178) |
| [NIH](https://specstream.ai/data/research-funding/organization/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | July 15, 2020 | Discovery of antiviral inhibitors of Ebola virus replication; $300 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10216627) |
| [NIH](https://specstream.ai/data/research-funding/organization/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | July 1, 2020 | Development of Therapeutic Products for Antibiotic Resistant Bacteria; $21.8 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/11424312) |
| [NIH](https://specstream.ai/data/research-funding/organization/venatorx-pharmaceuticals-inc-mbbknbu5dcc6) | September 5, 2019 | New class of PBP inhibitors to address PBP2-mediated resistance in Neisseria gonorrhoeae; $4.6 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/10686113) |

- [Venatorx Pharmaceuticals, Inc.](https://specstream.ai/data/research-funding/organization/venatorx-pharmaceuticals-inc-mbbknbu5dcc6)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (Pennsylvania), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Pennsylvania

- [Pharmaceutical companies in Pennsylvania, United States](https://specstream.ai/data/businesses/pharmaceutical-companies/pennsylvania-united-states)
- [Electric utilities in Pennsylvania, United States](https://specstream.ai/data/businesses/electric-utilities/pennsylvania-united-states)
- [Vending machine suppliers in Pennsylvania, United States](https://specstream.ai/data/businesses/vending-machine-suppliers/pennsylvania-united-states)
- [Medical research institutes in Pennsylvania, United States](https://specstream.ai/data/businesses/medical-research-institutes/pennsylvania-united-states)
- [Computer hardware companies in Pennsylvania, United States](https://specstream.ai/data/businesses/computer-hardware-companies/pennsylvania-united-states)
- [Specialty schools in Pennsylvania, United States](https://specstream.ai/data/businesses/specialty-schools/pennsylvania-united-states)
